Literature DB >> 2657830

Validation of a computerized assessment (PROQSY) of minor psychological morbidity by Relative Operating Characteristic analysis using a single GP's assessments as criterion measures.

G Wilkinson1, A C Markus.   

Abstract

This is a study of the criterion validity of a newly developed computerized assessment (PROQSY) of minor psychological morbidity based on the Clinical Interview Schedule, employing a single GP's assessments as criterion measures of such morbidity and Relative Operating Characteristic (ROC) analysis. Two-stage screening was carried out with a consecutive sample of 256 patients aged 15-69 consulting an experienced GP in a semi-rural setting over a six-week period. The GP made a standardized assessment of the reason for consultation and the degree of psychological disorder present. A 40% random sub-sample was then assessed using PROQSY. The area under the ROC curve using a GP criterion of minor psychological disorder ('degree of psychological problem - mild or greater') was 0.81 (S.D. = 0.06). However, the kappa coefficient obtained between this criterion assessment and the PROQSY assessment of minor psychological problem at the observed optimal cut-off score was only 0.28 (S.E. = 0.1; Z = 2.83). It is concluded that PROQSY may be recommended for further development as a research tool providing a valid measure of minor psychological morbidity as assessed by GPs in primary care settings.

Entities:  

Mesh:

Year:  1989        PMID: 2657830     DOI: 10.1017/s0033291700011193

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  2 in total

1.  Assessment of psychological care in general practice.

Authors:  D Crossley; M P Myres; G Wilkinson
Journal:  BMJ       Date:  1992-11-28

2.  Measurement of behaviour difficulties in children using standard scales administered to mothers by computer: Reliability and validity.

Authors:  Ian Berg; Christopher Lucas; Ralph McGuire
Journal:  Eur Child Adolesc Psychiatry       Date:  1992-01       Impact factor: 4.785

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.